Suzanne Crandall, DO
Neurology · Charleston, WVNPI 1679761498
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 61.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $4,751 and has fallen 83.6% since, to $777 in 2025.
Across 96 payments — averaging $119.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Medtronic$2K
- UCB, Inc.$851
- Neurelis, Inc.$289
- AstraZeneca$251
- Biogen$207
- plus $940 from 16 others
What the payments were for
- Consulting fees$1501%
- Speaking & faculty fees$5,55048%
- Travel & lodging$2,28620%
- Food & beverage$3,48630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $7,005 |
| Medtronic(2 entities) | 13 | $1,932 |
| UCB, Inc. | 9 | $851 |
| Neurelis, Inc. | 6 | $289 |
| AstraZeneca(2 entities) | 5 | $251 |
| Biogen | 5 | $207 |
| SK Life Science, Inc. | 3 | $163 |
| Neurocrine Biosciences, Inc. | 2 | $144 |
| Alnylam Pharmaceuticals Inc. | 1 | $110 |
| Jazz Pharmaceuticals Inc. | 1 | $96 |
| Lilly USA, LLC | 4 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Novartis | 3 | $54 |
| Amgen | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Acadia Pharmaceuticals Inc | 1 | $32 |
| Bristol Myers Squibb | 2 | $26 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Pfizer | 1 | $16 |
| Sanofi | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,473 in reported general payments places this provider in the 75th percentile of 93 neurology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $320 |
Paid to pharmacies, not to this prescriber.
Other neurology in Charleston
- Muhammed Nasher-AlneamCharleston$73K
- Lauren SeebergerCharleston$72K
- Gregory MathewsCharleston$30K
- David LardizabalCharleston$10K
- Darshankumar DaveCharleston$3K
- Joby JosephCharleston$2K
- Kris MurthyCharleston$2K
- Carolyn NeffCharleston$1K
- Braydon DymmCharleston$895
- Farrukh ShaikhCharleston$468
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.